| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,340,000,000 |
| Market
Cap: |
109.04(B) |
| Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
| 52
Week Range: |
$69.43 - $90.4 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 125 |
| Guru Rank Value : 7.5 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
854 |
36,546 |
56,412 |
75,447 |
| Total Sell Value |
$71,002 |
$3,094,660 |
$4,783,517 |
$6,318,268 |
| Total People Sold |
1 |
3 |
5 |
5 |
| Total Sell Transactions |
1 |
3 |
8 |
10 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ishrak Omar |
Chairman & CEO |
• • – |
2017-03-15 |
4 |
AS |
$82.82 |
$7,868,014 |
D/D |
(95,000) |
550,616 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2017-03-15 |
4 |
OE |
$38.81 |
$2,910,750 |
D/D |
75,000 |
645,616 |
|
- |
|
| Hogan Randall J |
Director |
• • – |
2017-03-02 |
4 |
OE |
$27.38 |
$413,684 |
D/D |
15,109 |
32,458 |
|
- |
|
| Hakami Hooman |
EVP & Group President Diabetes |
• • – |
2017-03-02 |
4 |
S |
$82.33 |
$4,307,019 |
D/D |
(52,316) |
58,929 |
|
- |
|
| Hakami Hooman |
EVP & Group President Diabetes |
• • – |
2017-03-02 |
4 |
OE |
$62.76 |
$3,283,352 |
D/D |
52,316 |
111,245 |
|
- |
|
| Craig Arnold |
Director |
• • – |
2017-03-01 |
4/A |
D |
$82.07 |
$572,931 |
D/D |
(6,981) |
25,932 |
|
- |
|
| Hanson Bryan C |
EVP, President, MITG |
• • – |
2017-02-17 |
4 |
D |
$78.88 |
$138,119 |
D/D |
(1,751) |
148,403 |
|
- |
|
| Lenehan James T |
Director |
• • – |
2017-01-05 |
4 |
OE |
$54.14 |
$183,372 |
D/D |
3,387 |
43,639 |
|
- |
|
| Ellis Gary Lee |
EVP & Global Ops and IT |
• • – |
2016-12-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
180,718 |
|
- |
|
| Pozen Robert C |
Director |
• • – |
2016-12-13 |
4 |
B |
$73.21 |
$999,983 |
D/D |
13,660 |
67,223 |
2.39 |
- |
|
| Hanson Bryan C |
EVP, President, MITG |
• • – |
2016-12-01 |
4 |
D |
$71.88 |
$298,661 |
D/D |
(4,155) |
149,586 |
|
- |
|
| Lenehan James T |
Director |
• • – |
2016-11-23 |
4 |
B |
$73.27 |
$146,533 |
D/D |
2,000 |
40,252 |
2.39 |
- |
|
| Surface Carol A |
SVP, Chief HR Officer |
• • – |
2016-10-28 |
4 |
D |
$81.93 |
$1,033,793 |
D/D |
(12,618) |
56,346 |
|
- |
|
| Kuntz Richard |
SrVP & Chief Scien, Clin, Reg |
• • – |
2016-09-27 |
4 |
S |
$86.70 |
$1,486,056 |
D/D |
(17,141) |
107,085 |
|
- |
|
| Kuntz Richard |
SrVP & Chief Scien, Clin, Reg |
• • – |
2016-09-26 |
4 |
S |
$86.67 |
$2,183,997 |
D/D |
(25,199) |
124,226 |
|
- |
|
| Kuntz Richard |
SrVP & Chief Scien, Clin, Reg |
• • – |
2016-09-26 |
4 |
OE |
$35.92 |
$1,100,014 |
D/D |
30,624 |
149,425 |
|
- |
|
| Ishrak Omar |
Chairman & CEO |
• • – |
2016-09-15 |
4 |
AS |
$84.93 |
$5,259,414 |
D/D |
(61,925) |
565,916 |
|
- |
|
| Powell Kendall J |
Director |
• • – |
2016-09-15 |
4 |
S |
$85.45 |
$675,614 |
D/D |
(7,907) |
26,375 |
|
- |
|
| Powell Kendall J |
Director |
• • – |
2016-09-15 |
4 |
OE |
$29.96 |
$447,083 |
D/D |
10,061 |
34,282 |
|
- |
|
| Hanson Bryan C |
EVP, President, MITG |
• • – |
2016-08-29 |
4 |
AS |
$87.00 |
$1,305,000 |
D/D |
(15,000) |
153,192 |
|
- |
|
| Hanson Bryan C |
EVP, President, MITG |
• • – |
2016-08-29 |
4 |
OE |
$29.52 |
$442,800 |
D/D |
15,000 |
168,192 |
|
- |
|
| Oleary Denise M |
Director |
• • – |
2016-08-16 |
4 |
OE |
$46.91 |
$70,037 |
D/D |
1,493 |
52,423 |
|
- |
|
| Coyle Michael J |
EVP & Group Pres, Cardiac&Vasc |
• • – |
2016-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
60,944 |
145,469 |
|
- |
|
| Lerman Bradley E |
SVP General Counsel & Corp Sec |
• • – |
2016-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,356 |
52,081 |
|
- |
|
| Kuntz Richard |
SrVP & Chief Scien, Clin, Reg |
• • – |
2016-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,842 |
118,801 |
|
- |
|
680 Records found
|
|
Page 21 of 28 |
|
|
0.77 (0.96%) 
